Galectin Therapeutics (GALT) Live Share Price, Invest From India

Galectin Therapeutics Stock Performance

as on August 27, 2026 at 2:15 pm IST

Day's Low
Day's High
$3.93
Day's Price Range
$4.21
$4.15
5.30%
Downside
1.45%
Upside
52 Week's Low
52 Week's High
$2.03
52-Week Price Range
$7.13
$4.15
51.20%
Downside
71.81%
Upside

Galectin Therapeutics share price movements today

Previous Close: $3.99
Open: $3.94
Volume: 515.8K
Market Cap: $391.3M
Day's Low - High: $3.93 - $4.21
52 Week Low - High: $2.03 - $7.13

Galectin Therapeutics Historical Returns

1 Month Return: + 18.05 %
3 Month Return: + 47.78 %
1 Year Return: + 0.25 %
3 Year Return: + 141.42 %
5 Year Return: + 2.84 %

Galectin Therapeutics Stock Fundamentals & Key Indicators

Check Galectin Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$391.3M

EPS (TTM)

-0.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-3727.95%

Galectin Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Galectin Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Galectin Therapeutics	BUY	$391.3M	2.84%	NA	0.00%	NA
Revolution Medicines	BUY	$45.3B	641.42%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$138.8B	176.54%	31.95	35.00%	NA
Moderna	BUY	$55.4B	-58.45%	NA	-141.43%	NA
Regeneron	BUY	$85.3B	25.67%	20.62	27.87%	44.39%

Stock Returns calculator for Galectin Therapeutics Stock including INR - Dollar returns

The Galectin Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Galectin Therapeutics investment value today

Current value as on today

₹1,13,513

Returns

₹13,513

(+13.51%)

Returns from Galectin Therapeutics Stock

₹4,271 (+4.27%)

Dollar Impact

₹9,242 (+9.24%)

Analyst Recommendation on Galectin Therapeutics Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Galectin Therapeutics. Average target price of $11

Galectin Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Galectin Therapeutics.

What analysts predicted

62.27%UPSIDE

Target Price

$11

Current Price

$4.15

Analyzed by

1 Analysts

Target

$11.00

Galectin Therapeutics target price $11, a slight upside of 62.27% compared to current price of $4.15. According to 1 analysts rating.

Indian Investors' Interest in Galectin Therapeutics Stock

Search interest for Galectin Therapeutics Stock has decreased by -39% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 28, 2026 to August 27, 2026

Change:-39% versus previous 30 day period

Galectin Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	0	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-	0	0
Operating Income	-9	-11	-9	-12	-7	-4	-4	-3	-4
EBITDA	-10	-11	-9	-10	-7	-5	-6	-3	-3
Interest Expense	1	1	1	1	1	1	1	1	1
Depreciation	0	0	0	0	0	0	-	0	0
Income Before Tax	-11	-12	-11	-11	-9	-7	-8	-5	-5
Income Tax Expense	0	-	-	-	-	-	-	-	-
Net Income	-11	-12	-11	-11	-9	-7	-8	-5	-5
Net Profit Margin	0.00%	0.00%	0.00%	-33241.67%	0.00%	0.00%	0.00%	0.00%	0.00%

Galectin Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	-
Operating Income	-21	-16	-13	-13	-23	-30	-38	-38	-42	-20
EBITDA	-21	-16	-13	-13	-23	-29	-37	-38	-41	-23
Interest Expense	-	0	0	0	0	0	1	2	5	7
Depreciation	-	0	-	0	0	0	0	0	0	0
Income Before Tax	-21	-16	-13	-13	-23	-30	-38	-41	-47	-30
Income Tax Expense	-	0	-	0	0	0	0	-2	-	-
Net Income	-21	-16	-13	-13	-23	-30	-38	-41	-47	-30
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Galectin Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-12	-11	-11	-9	-7	-8	-5	-5	-9
Operating Cash Flow	-8	-8	-12	-7	-6	-3	-6	-3	-2
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	10	10	0	-	12	1	12	0	1
Change in Cash	2	1	-11	-7	6	-2	6	-3	0

Galectin Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-16	-13	-13	-23	-30	-38	-41	-47	-30
Operating Cash Flow	-15	-10	-10	-20	-24	-31	-32	-41	-23
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	3	15	50	0	36	10	40	31	26
Change in Cash	-12	5	39	-20	12	-21	7	-10	2

Mutual Funds that own Galectin Therapeutics Stock

Check out the Mutual Funds with significant holdings in Galectin Therapeutics.

Funds	Holdings	Shares Held
VANGUARD INDEX FUNDS	1.898938%	1915073
Fidelity Concord Street Trust	0.531746%	536264
SCHWAB CAPITAL TRUST	0.029717%	29970
VANGUARD VALLEY FORGE FUNDS	0.026675%	26902
VANGUARD INSTITUTIONAL INDEX FUNDS	0.02436%	24567

See all

Global Institutional Holdings in Galectin Therapeutics

Funds	Holdings
Vanguard	2.44%
iShares	1.66%
SPDR	0.05%
Xtrackers	0.04%
Horizon Kinetics	0.04%

See all

Insights on Galectin Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, GALT stock has moved up by 16.2%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, GALT has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 496.3% return, outperforming this stock by 492.0%

About Galectin Therapeutics

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in a Phase 2 clinical study in MASH patients with advanced fibrosis and a second Phase 2b clinical trial in MASH patients with compensated cirrhosis and portal hypertension. It has a joint venture co-owned by SBH Sciences, Inc. to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Organisation	Galectin Therapeutics
Headquarters	4960 Peachtree Industrial Boulevard, Norcross, GA, United States, 30071
Industry	Biotechnology
CEO	Mr. Joel Lewis CPA
E-voting on shares	Click here to vote

Key Management of Galectin Therapeutics

Name	Title
Mr. Joel Lewis CPA	President & CEO
Mr. Jack W. Callicutt CPA	CFO, Treasurer & Corporate Secretary
Dr. Khurram Jamil M.D.	Chief Medical Officer
Mr. Robert Tritt J.D.	General Counsel
Mr. Jim Wilkins Ph.D.	Head of CMC & Pharmaceutical Development
Ms. Beth Knowles	Executive Assistant & Officer Manager

FAQs

What is Galectin Therapeutics share price today?

Galectin Therapeutics share price today is $4.15 as on August 27, 2026 at 8:45 am IST at the close of the market. Galectin Therapeutics share today touched a day high of $4.21 and a low of $3.93.

What is the 52 week high and 52 week low for Galectin Therapeutics share?

Galectin Therapeutics share touched a 52 week high of $7.13 on January 1, 1970 and a 52 week low of $2.03 on January 1, 1970. Galectin Therapeutics stock price today i.e. August 27, 2026 at 8:45 am IST is closed at $4.15,which is 41.80% down from its 52 week high and 104.94% up from its 52 week low.

What is Galectin Therapeutics's market capitalisation today?

Galectin Therapeutics market capitalisation is $0.00T as on August 27, 2026 at 8:45 am IST.

How to invest in Galectin Therapeutics Stock (GALT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Galectin Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Galectin Therapeutics Shares that will get you 0.3614 shares as per Galectin Therapeutics share price of $4.15 per share as on August 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy Galectin Therapeutics Stock (GALT) from India?

Indian investors can start investing in Galectin Therapeutics (GALT) shares with as little as ₹95.402 or $1 (as of August 27, 2026 at 12:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹954.02 in Galectin Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 27, 2026 at 12:40 pm IST). Based on Galectin Therapeutics share’s latest price of $4.15 as on August 27, 2026 at 8:45 am IST, you will get 2.4096 shares of Galectin Therapeutics. Learn more about fractional shares .

What are the returns that Galectin Therapeutics has given to Indian investors in the last 5 years?

Galectin Therapeutics stock has given 2.84% share price returns and 29.12% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?